M-Power New York City: Community Workshop
Know the risks and symptoms of multiple myeloma, the most common blood
cancer in African Americans, and how to get the best care.
Join Us at M-Power New York: Heritage, Health, and Hope
Experts in the field will share vital information to raise awareness of Black patients and families who are just getting started with their myeloma journey. Interviews with a myeloma expert, a clinical trial nurse, and a clinical trial patient will also be conducted during the workshop.
Participants will have the chance to listen to presentations, ask questions, and gain valuable knowledge from myeloma experts in the field.
This educational event will conclude with a Q&A where participants can directly engage with IMF Chief Medical Officer Dr. Joseph Mikhael and other myeloma experts for any questions involving the topics of discussion.
With support from:
Abbvie, Amgen, The Binding Site, Genentech, GSK, Johnson & Johnson, Karyopharm Therapeutics, Kite Pharma, Sanofi, and Sebia.
The International Myeloma Foundation’s M-Power Project Workshop for Health Equity in Myeloma in NY
The M-Power New York workshop took place at Riverside Church and Grace Baptist Church in New York, discussing multiple myeloma and its impact on the African-American community. It is organized by the International Myeloma Foundation in partnership with Memorial Sloan Kettering Cancer Center. The event aims to bridge the health disparity and empower people to make a change. The event is held at Riverside Church and Grace Baptist Church in New York, in partnership with Memorial Sloan Kettering Cancer Center. Dr. Joseph Mikhael, the Chief Medical Officer of the International Myeloma Foundation, serves as the host of the event.Focusing on awareness of multiple myeloma in the African American community and living a healthier life.
The M-Power Project realizes the IMF Diversity Initiative’s vision, enhancing outcomes for African-American myeloma patients. Though the most common blood cancer in this group, with reduced barriers to diagnosis and treatment, they fare as well as or even better than white individuals. Empowering healthcare professionals, community leaders, neighborhoods, and families, M-Power raises myeloma awareness.
Artist Ice-T Shined a Light on Myeloma in New York's Times Square
Discover how Ice-T, renowned actor and artist, raised awareness of multiple myeloma in the African American community during Black History Month. In a gripping PSA, Ice-T highlights the prevalence of myeloma in African Americans and urges community members to educate themselves and recognize the signs and symptoms. Don’t miss out on this important message. Learn more about myeloma awareness and Ice-T’s advocacy efforts.
%
of all cases of myeloma are in African Americans
more common in African Americans
%
of all newly diagnosed myeloma patients will be African American
Multiple Myeloma
Did you know that myeloma is the most common blood cancer in people of African descent? But doctors do not typically check people for myeloma during a regular visit because currently there are no national screening recommendations for myeloma.
That’s why it’s important to learn the early symptoms of myeloma and let your doctor know that you—or a friend or family member—are at added risk for the disease.
Because even though myeloma affects African Americans at greater rates, with early diagnosis and treatment, African Americans can have better overall survival in living with the disease.
MYELOMA TOOLKIT
A Day in the Life –
Terrence and Toni Green
You’re listening to A Day in the Life Podcast, brought to you by the International Myeloma Foundation. We hope this podcast provides messages of hope and resilience for those in the myeloma community and beyond. Today we’re talking to myeloma patient Terrence Green and his spouse and care partner Toni Green.
Abstracts on racial disparities in myeloma care
IMF Chief Medical Officer Dr. Joseph Mikhael (TGen, City of Hope — Phoenix) talks about abstracts on racial disparities in myeloma care as reported from this year’s American Society of Hematology (ASH) annual conference held in Atlanta, GA.
Patient advocate Yelak Biru shares his story
Diagnosed at the young age of 25 with stage III multiple myeloma, Yelak Biru is a patient turned myeloma research advocate. Working with a team of medical practitioners and educating himself through support group leadership, information resources, advocacy sites, social media, and the IMF, Yelak has successfully integrated myeloma to his life for over two decades.